Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Paola Ferrari
Observed names:
P Ferrari,
P. FERRARI,
P. Ferrari
Institutions:
Azienda Ospedaliera Universitaria Pisana,
Sapienza University of Rome
Observed institutions:
University of Pisa,
Istituto di Fisiologia Clinica,
Azienda Ospedaliera Universitaria Pisana,
Sapienza University of Rome,
University of Bologna
ORCID:
0000-0003-2983-9726
Observed ORCID:
0000-0003-2983-9726
OpenAlex ID:
A5056157710
Prognostic and predictive biomarkers in breast cancer: Past, present and future
2017
·
Andrea Nicolini
, Paola Ferrari
, et al.
·
Seminars in Cancer Biology
·
430
Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC
2022
·
Paola Ferrari
, Cristian Scatena
, et al.
·
International Journal of Molecular Sciences
·
210
Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy
2024
·
Andrea Nicolini
, Paola Ferrari
·
Frontiers in Immunology
·
191
Malnutrition, anorexia and cachexia in cancer patients: A mini-review on pathogenesis and treatment
2013
·
Andrea Nicolini
, Paola Ferrari
, et al.
·
Biomedicine & Pharmacotherapy
·
171
Metastatic breast cancer: an updating
2006
·
A. Nicolini
, R. Giardino
, et al.
·
Biomedicine & Pharmacotherapy
·
121
Exosomes and Cell Communication: From Tumour-Derived Exosomes and Their Role in Tumour Progression to the Use of Exosomal Cargo for Cancer Treatment
2021
·
Andrea Nicolini
, Paola Ferrari
, et al.
·
Cancers
·
96
PDF
Effects of cachexia due to cancer on whole body and skeletal muscle protein turnover
1998
·
Federica Dworzak
, Paola Ferrari
, et al.
·
Cancer
·
95
PDF
Sunitinib in the Treatment of Thyroid Cancer
2017
·
Silvia Martina Ferrari
, Marco Centanni
, et al.
·
Current Medicinal Chemistry
·
90
Increase of Circulating CXCL9 and CXCL11 Associated with Euthyroid or Subclinically Hypothyroid Autoimmune Thyroiditis
2011
·
Alessandro Antonelli
, Silvia Martina Ferrari
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
74
Oral low-dose cyclophosphamide in metastatic hormone refractory prostate cancer (MHRPC)
2004
·
A Nicolini
, PA Mancini
, et al.
·
Biomedicine & Pharmacotherapy
·
71
Endocrine Response Determines the Clinical Outcome of Pulsatile Gonadotropin-Releasing Hormone Ovulation Induction in Different Ovulatory Disorders*
1991
·
M. FILICORI
, C. FLAMIGNI
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
65
Defective Generation and Maturation of Dendritic Cells from Monocytes in Colorectal Cancer Patients during the Course of Disease
2013
·
Giulia Orsini
, Annalisa Legitimo
, et al.
·
International Journal of Molecular Sciences
·
62
PDF
Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases
2006
·
Andrea Nicolini
, Gianna Tartarelli
, et al.
·
BMC Cancer
·
62
PDF
Treatment of mild non-chemotherapy-induced iron deficiency anemia in cancer patients: Comparison between oral ferrous bisglycinate chelate and ferrous sulfate
2012
·
Paola Ferrari
, Andrea Nicolini
, et al.
·
Biomedicine & Pharmacotherapy
·
52
The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy
1999
·
A Nicolini
, P Ferrari
, et al.
·
British Journal of Cancer
·
51
PDF
Cytokines in the Management of High Risk or Advanced Breast Cancer: An Update and Expectation
2009
·
A. Carpi
, A. Nicolini
, et al.
·
Current Cancer Drug Targets
·
48
Immunotherapy and Hormone-therapy in Metastatic Breast Cancer: A Review and an Update
2016
·
Andrea Nicolini
, Angelo Carpi
, et al.
·
Current Drug Targets
·
46
Cancer: A Problem of Developmental Biology; Scientific Evidence for Reprogramming and Differentiation Therapy
2016
·
Stewart Sell
, Andrea Nicolini
, et al.
·
Current Drug Targets
·
43
Stem Cells: Their Role in Breast Cancer Development and Resistance to Treatment
2011
·
A. Nicolini
, P. Ferrari
, et al.
·
Current Pharmaceutical Biotechnology
·
42
Tumour growth and immune evasion as targets for a new strategy in advanced cancer
2018
·
Andrea Nicolini
, Paola Ferrari
, et al.
·
Endocrine Related Cancer
·
29
PDF
The role of tumour markers in improving the accuracy of conventional chest X-ray and liver echography in the post-operative detection of thoracic and liver metastases from breast cancer
2000
·
A Nicolini
, A Carpi
, et al.
·
British Journal of Cancer
·
29
PDF
The PI3K-AKt-mTOR Pathway and New Tools to Prevent Acquired Hormone Resistance in Breast Cancer
2015
·
Andrea Nicolini
, Paola Ferrari
, et al.
·
Current Pharmaceutical Biotechnology
·
27
Minimal residual disease in advanced or metastatic solid cancers: The G0-G1 state and immunotherapy are key to unwinding cancer complexity
2020
·
Andrea Nicolini
, Giuseppe Rossi
, et al.
·
Seminars in Cancer Biology
·
26
Mucins and Cytokeratins as Serum Tumor Markers in Breast Cancer
2015
·
Andrea Nicolini
, Paola Ferrari
, et al.
·
Advances in experimental medicine and biology
·
25
Quantification of Blood Dendritic Cells in Colorectal Cancer Patients During the Course of Disease
2013
·
Giulia Orsini
, Annalisa Legitimo
, et al.
·
Pathology & Oncology Research
·
25
Show more works
View as search
Works count:
116
Citation count:
2,578
H-index:
25
I10-index:
46
Year
Topic
Type